The History of Cannabis: From Ancient Medicine to Modern Science

A Plant Older Than Writing Itself

Here’s a fact that might change how you think about cannabis: humans have been using it for longer than we’ve been writing things down. The earliest physical evidence of cannabis use — charred seeds found in a ritual brazier — dates back roughly 2,500 years to the Pamir Mountains of Central Asia [Ren et al., 2019]. But the plant’s relationship with our species stretches back even further, with archaeological evidence of hemp fiber use reaching nearly 10,000 years into the past [Long et al., 2017].

Cannabis has been intertwined with human civilization for essentially all of recorded history — and a good chunk of prehistory, too. It has been a medicine, a fiber, a spiritual sacrament, a political flashpoint, and now, a subject of rigorous scientific inquiry. Understanding this arc isn’t just a history lesson. It may change how you think about the plant today.

Why does this matter to your actual cannabis experience? Because the science we’re rediscovering now — the terpene profiles, the cannabinoid interactions, the entourage effect — isn’t really new at all. Ancient practitioners understood, through millennia of observation, that different preparations of cannabis produced different effects. They didn’t have gas chromatographs or peer-reviewed journals, but they had something equally valuable: thousands of years of careful, empirical use.

In this article, we’ll walk through that entire journey — from the earliest documented uses in ancient China and India, through the plant’s global spread, its golden age in Western medicine, the dark century of prohibition, and the scientific renaissance happening right now. By the end, you’ll understand not just where cannabis has been, but why the modern, science-backed approach to choosing cannabis — through terpene chemistry and High Families — may be the culmination of humanity’s oldest botanical relationship.

The Ancient World: Cannabis as Sacred Medicine

The Chinese Pharmacopoeia

The earliest written record of cannabis as medicine comes from the Pen Ts’ao Ching, a Chinese pharmacopoeia traditionally attributed to Emperor Shen Nung around 2737 BCE — though scholars believe the text was compiled much later, around the 1st or 2nd century CE, from older oral traditions [Brand & Zhao, 2017]. The text describes ma (麻, cannabis) as a treatment for ailments including gout, rheumatism, malaria, and what we might today describe as cognitive decline.

What’s notable is that ancient Chinese physicians already recognized cannabis preparations varied in their effects. The Pen Ts’ao noted that the plant’s flowers, seeds, and leaves had different properties — an early, intuitive understanding of what we now know to be the varying concentrations of cannabinoids and terpenes across different parts of the plant.

Chinese surgeon Hua Tuo (c. 140–208 CE) is credited with developing mafeisan, an anesthetic powder believed to contain cannabis, which he reportedly used during surgical procedures [Brand & Zhao, 2017]. The concept of using cannabis for pain management is, quite literally, ancient.

Ayurvedic and Vedic Traditions

Across the Himalayas in India, cannabis held an equally prominent — and perhaps even more celebrated — role. The Atharva Veda, one of Hinduism’s four sacred texts composed between 1500 and 1000 BCE, lists cannabis (bhanga) as one of five sacred plants and describes it as a “source of happiness” and a “liberator” [Russo, 2007].

Indian Ayurvedic medicine developed sophisticated cannabis preparations, including bhang (a drink made from cannabis leaves and milk), ganja (smoked flower), and charas (hand-rolled resin, essentially the world’s first concentrate). Each preparation was understood to produce different intensities and qualities of effect — a framework that maps surprisingly well onto modern terpene science.

Consider: bhang, made primarily from leaves with lower cannabinoid and terpene concentrations, produced gentler, more balanced effects — similar to what we’d now classify as a Balancing High. Charas, a concentrated resin rich in the full spectrum of the plant’s chemistry, delivered the kind of complex, layered experience we’d associate with an Entourage High. Ancient practitioners were, in essence, curating terpene profiles without knowing the chemistry.

The Scythians, Egypt, and the Ancient Mediterranean

Cannabis use wasn’t confined to Asia. The Greek historian Herodotus, writing around 440 BCE, described the Scythians — nomadic peoples of Central Asia — throwing cannabis onto hot stones inside small tents, inhaling the vapor, and “howling with pleasure” [Herodotus, Histories, Book IV]. The archaeological discovery at the Jirzankal Cemetery in the Pamir Mountains in 2019 confirmed this practice with physical evidence: wooden braziers containing cannabis residue with unusually high THC levels [Ren et al., 2019].

In Egypt, the Ebers Papyrus (c. 1550 BCE), one of the oldest complete medical texts in existence, references shemshemet (cannabis) as an ingredient in preparations for inflammation and eye conditions [Russo, 2007]. Meanwhile, the ancient Assyrians used cannabis as an incense they called qunubu — which many linguists believe is the etymological root of the word “cannabis” itself.

Key Takeaway: Cannabis wasn’t a fringe substance in the ancient world — it appears to have been mainstream medicine, spiritual sacrament, and cultural cornerstone across multiple civilizations simultaneously.

The Western Medical Golden Age and the Fall

Cannabis Enters Western Medicine

The modern Western encounter with cannabis medicine is largely credited to Irish physician William Brooke O’Shaughnessy, who studied the plant’s therapeutic uses while working in Calcutta in the 1830s and 1840s. O’Shaughnessy conducted early clinical observations — testing cannabis preparations on patients with rabies, rheumatism, epilepsy, and tetanus — and published his findings in 1843, sparking significant interest across Europe and America [Russo, 2007].

By the mid-to-late 1800s, cannabis tinctures were among the most commonly prescribed medicines in the Western world. Pharmaceutical companies including Eli Lilly, Parke-Davis, and Squibb all manufactured cannabis products. Queen Victoria’s personal physician, Sir J. Russell Reynolds, wrote in The Lancet in 1890 that cannabis was “one of the most valuable medicines we possess” for conditions including menstrual pain and migraine [Reynolds, 1890].

This was a golden age. Between 1840 and 1900, more than 100 scientific papers were published on the therapeutic applications of cannabis in Western medical journals [Russo, 2007]. The plant was listed in the United States Pharmacopeia from 1850 to 1942.

The Unraveling: Prohibition

So what happened? The story of cannabis prohibition is less a scientific narrative and more a political one — driven by a combination of racism, economic interests, and bureaucratic expansion.

In the early 20th century, anti-cannabis sentiment in the United States was fueled in part by xenophobia directed at Mexican immigrants and African American communities. Harry Anslinger, the first commissioner of the Federal Bureau of Narcotics, ran a propaganda campaign in the 1930s that deliberately rebranded the plant as “marihuana” — a Spanish-language term designed to associate it with Mexican immigrants and stoke racial fear [Bonnie & Whitebread, 1974].

The Marihuana Tax Act of 1937 effectively criminalized cannabis in the United States, despite objections from the American Medical Association. The global dominoes fell in sequence: the United Nations Single Convention on Narcotic Drugs in 1961 classified cannabis as a Schedule I substance internationally, and the U.S. Controlled Substances Act of 1970 cemented its status as a drug with “no accepted medical use.”

For nearly a century, the world’s oldest continuously used medicine was, on paper, considered to have no medical value whatsoever.

What Was Lost

The prohibition era didn’t just stop people from using cannabis — it stopped scientists from studying it. Decades of potential research were frozen. The understanding that ancient cultures had built over millennia — that different preparations produced different effects, that the whole plant worked differently than its parts — was largely dismissed.

It’s worth sitting with that for a moment. Imagine if aspirin had been banned in 1937 and only started being studied again in the 1990s. That’s roughly what happened with cannabis.

The Scientific Renaissance: Rediscovering What the Ancients Knew

The Endocannabinoid System

The modern scientific story of cannabis begins in 1964, when Israeli chemist Raphael Mechoulam and his colleague Yechiel Gaoni first isolated and synthesized THC (Δ9-tetrahydrocannabinol) — the primary psychoactive compound in cannabis [Gaoni & Mechoulam, 1964]. This was a landmark moment, but the bigger revelation came later.

In 1988, researchers at St. Louis University discovered the first cannabinoid receptor in the brain — CB1 [Devane et al., 1988]. In 1993, a second receptor — CB2 — was identified primarily in the immune system [Munro et al., 1993]. And in 1992, Mechoulam’s team discovered anandamide, the body’s own endogenous cannabinoid, naming it after the Sanskrit word ananda, meaning “bliss” [Devane et al., 1992].

Think of it this way: imagine discovering that your body has an entire communication network — the endocannabinoid system (ECS) — that appears to help regulate mood, pain, appetite, sleep, immune function, and memory. And then discovering that the cannabis plant produces compounds that interact with this system like keys fitting into locks. That’s what happened between 1964 and the early 2000s, and it changed our understanding of both human biology and cannabis.

The ECS is now understood to be one of the more important regulatory systems in the human body, thought to be involved in maintaining homeostasis — the body’s internal balance [Lu & Mackie, 2016]. This is likely why cannabis appears to influence such a wide range of experiences: it’s not targeting one specific thing, it’s interacting with a system that touches many things at once.

Beyond THC: The Entourage Effect and Terpene Science

Here’s where ancient wisdom and modern science appear to converge.

For decades after Mechoulam’s discovery of THC, the scientific and commercial focus was almost entirely on isolated cannabinoids — THC for recreation, CBD for wellness. But researchers began noticing something that ancient practitioners may have intuited all along: whole-plant cannabis worked differently than its isolated components.

In 1998, Mechoulam and Shimon Ben-Shabat proposed the concept of the entourage effect — the idea that cannabis compounds work synergistically, with terpenes, flavonoids, and minor cannabinoids modulating and enhancing the effects of major cannabinoids [Ben-Shabat et al., 1998]. Ethan Russo expanded this framework significantly in his 2011 paper, “Taming THC,” which detailed specific mechanisms by which terpenes like myrcene, limonene, linalool, and caryophyllene may influence the cannabis experience [Russo, 2011].

This research suggested what Ayurvedic practitioners may have understood thousands of years ago: how you prepare cannabis matters because the full chemical profile — not just one compound — shapes the experience.

This is the principle behind the High Families classification system. Rather than relying on the outdated and scientifically questionable indica/sativa binary — which genetic research has shown to be largely unreliable for predicting effects [Watts et al., 2021] — High Families groups cannabis experiences by their terpene chemistry:

• Limonene and linalool dominant profiles tend to produce mood elevation and social energy → Uplifting High
• Terpinolene and ocimene profiles lean toward focused productivity → Energetic High
• Myrcene-heavy and high-CBD profiles may support deep relaxation → Relaxing High
• Caryophyllene and humulene profiles focus on physical comfort → Relieving High
• Complex multi-terpene profiles deliver nuanced, full-spectrum experiences → Entourage High
• Low-terpene, gentle profiles offer approachable experiences → Balancing High

This is the practical application of entourage effect research. And it’s a direct line from the ancient Indian understanding that bhang, ganja, and charas each delivered distinct experiences, to the modern understanding that terpene profiles are a key factor in predicting your high.

Practical Implications: What History Teaches Us About Today

Choose by Chemistry, Not by Name

The single most practical lesson from 5,000 years of cannabis history may be this: the plant’s chemical profile matters more than its name. Ancient practitioners didn’t have strain names — they had preparations, each with a distinct chemical character. Modern science appears to confirm this approach. When choosing cannabis, looking at the terpene profile and cannabinoid ratios — rather than just the strain name or an “indica” vs. “sativa” label — is likely more informative.

Start With Your Desired Experience

Ancient medical traditions consistently matched specific cannabis preparations to specific outcomes. Modern terpene science may allow you to do something similar with greater precision. Want creative social energy? Look for limonene-forward profiles in the Uplifting High family. Need deep physical relaxation? Seek out myrcene-dominant strains in the Relaxing High family.

Respect the Whole Plant

The entourage effect research suggests that isolated compounds may not deliver the same benefits as whole-plant preparations [Russo, 2011]. This echoes thousands of years of traditional use, where whole-plant preparations were consistently preferred over extracts. While modern concentrates and isolates have their place, the evidence suggests that the full ensemble of cannabis compounds working together may be one of the most important insights from both ancient practice and modern science.

Acknowledge What We Still Don’t Know

Perhaps the most humbling lesson from this history is how much was lost during prohibition. We’re still in the early stages of rediscovering what ancient cultures spent millennia understanding. Modern cannabis research is growing rapidly, but much of it remains preliminary — animal studies, small sample sizes, observational data. We should be curious and optimistic about the direction of the science without overstating what has been definitively proven.

Key Takeaways

• Cannabis is humanity’s oldest continuously documented medicine, with records spanning at least 5,000 years across dozens of cultures on multiple continents.
• The endocannabinoid system, discovered between 1988 and 1992, revealed that our bodies have a built-in regulatory network that appears to interact with cannabinoids — explaining why the plant has such broad-ranging effects.
• Prohibition, not science, drove cannabis off pharmacy shelves in 1937 — costing decades of potential research.
• The entourage effect — the idea that cannabis compounds work better together than in isolation — may validate what ancient practitioners understood intuitively about whole-plant preparations.
• Terpene chemistry, not indica/sativa labels, appears to be the more reliable guide to predicting cannabis effects — and is the science behind the High Families framework.
• We’re still early. The modern scientific renaissance of cannabis research is exciting, but much remains to be studied. Approach claims with curiosity and appropriate skepticism.

Sources

• Ben-Shabat, S., et al. (1998). An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. European Journal of Pharmacology, 353(1), 23–31.
• Bonnie, R.J., & Whitebread, C.H. (1974). The Marihuana Conviction: A History of Marihuana Prohibition in the United States. University Press of Virginia.
• Brand, E.J., & Zhao, Z. (2017). Cannabis in Chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids? Frontiers in Pharmacology, 8, 108.
• Devane, W.A., et al. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology, 34(5), 605–613.
• Devane, W.A., et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946–1949.
• Gaoni, Y., & Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society, 86(8), 1646–1647.
• Long, T., et al. (2017). Cannabis in Eurasia: origin of human use and Bronze Age trans-continental connections. Vegetation History and Archaeobotany, 26(2), 245–258.
• Lu, H.C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological Psychiatry, 79(7), 516–525.
• Munro, S., et al. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365(6441), 61–65.
• Ren, M., et al. (2019). The origins of cannabis smoking: chemical residue evidence from the first millennium BCE in the Pamirs. Science Advances, 5(6), eaaw1391.
• Reynolds, J.R. (1890). Therapeutical uses and toxic effects of cannabis indica. The Lancet, 135(3473), 637–638.
• Russo, E.B. (2007). History of cannabis and its preparations in saga, science, and sobriquet. Chemistry & Biodiversity, 4(8), 1614–1648.
• Russo, E.B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
• Watts, G., et al. (2021). Genomic approaches to understanding cannabis effects. Trends in Plant Science, 26(1), 48–61.